SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001654954-23-004412
Filing Date
2023-04-05
Accepted
2023-04-05 06:19:03
Documents
1
Period of Report
2023-04-05

Document Format Files

Seq Description Document Type Size
1 LYNPARZA + IMFINZI MET ENDPOINT IN OVARIAN CANCER astrazenecaplcmasterform6.htm 6-K 37443
  Complete submission text file 0001654954-23-004412.txt   38599
Mailing Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA
Business Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA 011 44 20 7304 5000
ASTRAZENECA PLC (Filer) CIK: 0000901832 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-11960 | Film No.: 23801109
SIC: 2834 Pharmaceutical Preparations